Abstract
Objectives
The A/H1N1 mass vaccination program in Canada garnered considerable attention from the media, including extensive newspaper coverage. Media reports have been shown to influence the public’s health care decisions, including vaccination choices. We analyzed Canadian newspapers’ portrayal of the A/H1N1 vaccine including mention of risks and benefits of the vaccine and whether the article supported, questioned or was neutral about the vaccine.
Methods
We compiled a data set of Canadian newspaper articles (N=234) and conducted a frequency content analysis to examine discussion and/or mention of evidence concerning vaccination, risks of the A/H1N1 virus and the vaccine, and tone of article in regards to the vaccination program in Canada.
Results
Reasons for getting vaccinated appeared in 71.8% of the articles, whereas only 18.4% provided reasons against getting vaccinated. Discussion of evidence to support claims for or against getting vaccinated appeared in only 27.8% and 6.8% of the articles, respectively. Risks associated with contracting the A/H1N1 virus were discussed in 49.6% of the articles and risks of the A/H1N1 vaccine were discussed in 12.4% of the articles.
Conclusion
Newspaper coverage in Canada was largely supportive of the A/H1N1 mass vaccination program. However, serious risks associated with contracting the A/H1N1 virus were also frequently discussed in the print media. The news articles rarely presented direct evidence to support statements that the vaccine was safe, effective and properly tested. Known risks (such as potential allergic reactions and flu-like side effects) of the vaccine were rarely reported. The relationship between media portrayals and vaccine uptake warrants further research.
Résumé
Objectifs
Le programme de vaccination de masse contre le virus A/H1N1 au Canada a fait l’objet d’une couverture médiatique considérable, y compris dans les journaux. Il est démontré que ces reportages influencent les décisions du public à l’égard de la santé, notamment les choix concernant la vaccination. Nous avons analysé la représentation du vaccin anti-A/H1N1 dans les journaux canadiens, à savoir: la mention des risques et des avantages du vaccin et si l’article était pour ou contre le vaccin ou s’il était neutre à ce sujet.
Méthode
Nous avons compilé un jeu de données composé d’articles de journaux canadiens (N=234) et effectué une analyse de fréquence de contenu pour examiner la discussion et/ou la mention des preuves liées à la vaccination, les risques du virus A/H1N1 et du vaccin, et le ton de l’article à l’égard du programme de vaccination au Canada.
Résultats
Les raisons de se faire vacciner étaient citées dans 71,8 % des articles, tandis que seulement 18,4 % citaient des raisons de ne pas se faire vacciner. Une discussion des preuves à l’appui des allégations pour ou contre le vaccin ne figurait que dans 27,8 % et dans 6,8 % des articles, respectivement. Les risques associés au virus A/H1N1 étaient discutés dans 49,6 % des articles, et les risques du vaccin étaient discutés dans 12,4 % des articles.
Conclusion
Les journaux canadiens étaient en grande partie favorables au programme de vaccination de masse contre le virus A/H1N1. Les risques graves associés au virus étaient fréquemment cités dans la presse écrite. Les articles de fond ont cependant rarement présenté des preuves directes à l’appui des déclarations selon lesquelles le vaccin était sûr, efficace et dûment testé. Les risques connus du vaccin (comme les réactions allergiques possibles et les effets secondaires pseudo-grippaux) ont rarement été mentionnés. Le lien entre la représentation du programme dans les médias et l’acceptation du vaccin devrait faire l’objet d’une étude plus poussée.
References
World Health Organization. World now at the start of 2009 influenza pandemic, June 11, 2009. Available at: https://doi.org/www.who.int/mediacentre/news/ statements/2009/h1n1_pandemic_phase6_20090611/en/index.html (Accessed August 13, 2010).
World Health Organization. H1N1 in post-pandemic period, August 10, 2010. Available at: https://doi.org/www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/index.html (Accessed August 13, 2010).
Gardam M. H1N1 myth busters. The Globe and Mail 2009 October 27. Available at: https://doi.org/www.theglobeandmail.com/life/health/h1n1-swine-flu/h1n1-myth-busters/article1340101/ (Accessed August 30, 2010).
Welsh M, Balkissoon D. Confusion reigns in flu-shot clinics. The Toronto Star 2009 November 1. Available at: https://doi.org/www.thestar.com/news/gta/arti-cle/719358—confusion-reigns-in-flu-shot-clinics (Accessed August 30, 2010).
Lineups overwhelm H1N1 vaccine clinics. CBC News 2009 October 26. Available at: https://doi.org/www.cbc.ca/canada/calgary/story/2009/10/26/calgary-swine-flu-h1n1-vaccine.html (Accessed August 30, 2010).
Guidance Document on the Use of Pandemic Influenza A (H1N1) 2009 Inactivated Monovalent Vaccine. Ottawa, ON: Public Health Agency of Canada, 2009. Available at: https://doi.org/www.phac-aspc.gc.ca/alert-alerte/h1n1/vacc/mono-vacc/immuno-eng.php (Accessed August 30, 2010).
Statistics Canada. The Daily: Canadian community health survey: H1N1 vaccinations, 2010 July 19. Available at: https://doi.org/www.statcan.gc.ca/daily-quotidien/100719/dq100719b-eng.htm (Accessed August 30, 2010).
Danovaro-Holliday MC, Wood AL, LeBaron CW. Rotavirus vaccine and the news media, 1987–2001. JAMA 2002;287:1455–62.
Henrich N, Holmes B. The public’s acceptance of novel vaccines during a pandemic: A focus group study and its application to influenza H1N1. Emerging Health Threats J 2009;2:1–10.
Maurer J, Uscher-Pines L, Harris KM. Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: Does the source of information matter. Prev Med 2010;51(2):185–87.
Nougairède A, Lagier J, Ninove L, Sartor C, Badiaga S, Botelho E, et al. Likely correlation between sources of information and acceptability of A/H1N1 swine-origin influenza virus vaccine in Marseille, France. PLoS One 2010;5(6):e11292.
Dubé E, Gilca V, Sauvageau C, Boulianne N, Boucher FD, Bettinger JA, et al. Canadian family physicians’ and paediatricians’ knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine. BMC Research Notes 2010;3:102.
Bubela T, Nisbet MC, Borchelt R, Brunger F, Critchley C, Einsiedel E, et al. Science communication reconsidered. Nat Biotechnol 2009;27:514–18.
Ten Eyck TA. The media and the public opinion on genetics and biotechnology: Mirrors, windows, or walls. Public Underst Sci 2005;14:305–16.
Brumfiel G. Supplanting the old media. Nature 2009;458:274–77.
Berry TR, Wharf-Higgins J, Naylor PJ. SARS wars: An examination of the quantity and construction of health information in the news media. Health Commun 2007;21(1):35–44.
Lemal M, Van den Bulck J. Television news coverage about cervical cancer: Impact on female viewers’ vulnerability perceptions and fear. Eur J Public Health 2010;26:1–6.
Highlights of media science forum poll results on Canadians’ views of health research information in the media. Research Canada, 2007. Available at: https://doi.org/www.rc-rc.ca/en/content.php?doc=112 (Accessed August 30, 2010).
Hyde-Lay R. Media representations of allergy and asthma issues, policy and research. Health Law Review 2010;18(3):24–29.
Government of Canada announces intention to order 50.4 million doses of H1N1 vaccine. Public Health Agency of Canada, 2009 August 6. Available at: https://doi.org/www.phac-aspc.gc.ca/media/nr-rp/2009/2009_0806-eng.php (Accessed November 10, 2010).
Government of Canada issues guidance on H1N1 influenza vaccine sequencing. Public Health Agency of Canada, 2009 September 16. Available at: https://doi.org/www.phac-aspc.gc.ca/media/nr-rp/2009/2009_0916-eng.php (Accessed August 30, 2010).
Health Canada Approves Pandemic H1N1 Flu Vaccine for Canadians. Public Health Agency of Canada, 2009 October 21. Available at: https://doi.org/www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2009/2009_171-eng.php (Accessed November 10, 2010).
Riffe D, Lacy S, Fico F. Analyzing Media Messages: Using Quantitative Content Analysis in Research. Maweh, NJ: Lawrence Erlbaum Associates, 1998).
Neuendorf KA. The Content Analysis Guidebook. Thousand Oaks, CA: Sage Publications, 2002).
Bubela T, Caulfield T. Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers. CMAJ 2005;170(9):1399–407.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.
Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, et al. Guillain-Barré Syndrome following influenza vaccination. JAMA 2004;292:2478–81.
Nisbet MC, Mooney C. Framing science. Science 2007;316:56.
Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, Moatti J-P. Low acceptability of A/H1N1 pandemic vaccination in French adult population: Did public health policy fuel public dissonance. PLoS ONE 2010;5(4):e10199.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rachul, C.M., Ries, N.M. & Caulfield, T. Canadian Newspaper Coverage of the A/H1N1 Vaccine Program. Can J Public Health 102, 200–203 (2011). https://doi.org/10.1007/BF03404896
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03404896
Mots clés
- journaux
- vaccins antigrippaux
- Canada
Key words
- Newspapers
- influenza vaccines
- Canada